Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer-Reference-Cited by-同舟云学术

Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer

Published:2021-05-04 Issue:13 Volume:27 Page:3734-3743
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Börcsök Judit^ORCID,Diossy Miklos^ORCID,Sztupinszki Zsofia^ORCID,Prosz Aurel,Tisza Viktoria,Spisak Sandor^ORCID,Rusz Orsolya,Stormoen Dag R.^ORCID,Pappot Helle^ORCID,Csabai Istvan^ORCID,Brunak Søren,Mouw Kent W.,Szallasi Zoltan^ORCID

Funder

Research and Technology Innovation Fund

Breast Cancer Research Foundation

Kræftens Bekæmpelse

Novo Nordisk Foundation

Prostate Cancer Research Program

Det Frie Forskningsråd Sundhed og Sygdom

NCI

Velux Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic significance and clinical relevance of stem cell characteristic in bladder cancer;Heliyon;2024-02

2. Incidental detection of FGFR3 fusion via liquid biopsy leading to earlier diagnosis of urothelial carcinoma;npj Precision Oncology;2023-11-18

3. Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer;Clinical Genitourinary Cancer;2023-10

4. Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features;Frontiers in Oncology;2023-08-03

5. Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients;Scientific Reports;2023-07-20